ACCORD HEALTHCARE

METHOTREXATE

Manufacturer:

ACCORD HEALTHCARE

Methotrexate HCPCS:

J9255

HCPCS Code Descriptor:

Injection, methotrexate (accord) not therapeutically equivalent to j9250 and j9260, 50 mg

Category:

J Code

Methotrexate NDCs:

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Methotrexate:

METHOTREXATE is a Oncology drug manufactured by ACCORD HEALTHCARE and administered via the route of administration. The J Code: J9255 is aligned to the drug METHOTREXATE.

ACCESS PRICING AND MORE BY REGISTERING

J9255 Added Date:

January 1, 2024

J9255 Effective Date:

January 1, 2024

J9255 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Methotrexate billing and coding information.
Our team did not identify a source for Methotrexate patient assistance information. Please reach out to our team if you feel that this is a mistake.
METHOTREXATE prescribing information can be found at the link below:
Information regarding METHOTREXATE’s side effects can be found at MedlinePlus